Treatment of advanced ovarian cancer with neoadjuvant chemotherapy became more frequent between 2004 and 2013
Utilization of neoadjuvant chemotherapy began to increase in 2007
Neoadjuvant chemotherapy was adopted most rapidly among elderly women, and those with stage IV ovarian cancer